Mostard RLM - Search Results

1

Patient Activation for Self-Management in Patients with Idiopathic Pulmonary Fibrosis or Sarcoidosis.

Bloem AEM, Mostard RLM, Stoot N, Custers JWH, Vooijs M, Janssen DJA, van 't Hul AJ, Spruit MA. Bloem AEM, et al. Among authors: mostard rlm. Respiration. 2022;101(1):76-83. doi: 10.1159/000518216. Epub 2021 Aug 31. Respiration. 2022. PMID: 34515234

2

Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis.

Mostard RL, Verschakelen JA, van Kroonenburgh MJ, Nelemans PJ, Wijnen PA, Vöö S, Drent M. Mostard RL, et al. Respir Med. 2013 Mar;107(3):439-47. doi: 10.1016/j.rmed.2012.11.011. Epub 2012 Dec 19. Respir Med. 2013. PMID: 23261309 Free article.

3

Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.

Moor CC, Mostard RLM, Grutters JC, Bresser P, Aerts JGJV, Chavannes NH, Wijsenbeek MS. Moor CC, et al. Among authors: mostard rlm. Am J Respir Crit Care Med. 2020 Aug 1;202(3):393-401. doi: 10.1164/rccm.202002-0328OC. Am J Respir Crit Care Med. 2020. PMID: 32325005 Clinical Trial.

4

Severe Fatigue is Highly Prevalent in Patients with IPF or Sarcoidosis.

Bloem AEM, Mostard RLM, Stoot N, Vercoulen JH, Peters JB, Janssen DJA, Custers JWH, Spruit MA. Bloem AEM, et al. Among authors: mostard rlm. J Clin Med. 2020 Apr 20;9(4):1178. doi: 10.3390/jcm9041178. J Clin Med. 2020. PMID: 32325989 Free PMC article.

5

Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study.

Moor CC, Mostard RLM, Grutters JC, Bresser P, Aerts JGJV, Dirksen CD, Kimman ML, Wijsenbeek MS. Moor CC, et al. Among authors: mostard rlm. Respir Res. 2020 Jul 23;21(1):196. doi: 10.1186/s12931-020-01458-1. Respir Res. 2020. PMID: 32703201 Free PMC article. Clinical Trial.

6

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study.

Kahlmann V, Janssen Bonás M, Moor CC, van Moorsel CHM, Kool M, Kraaijvanger R, Grutters JC, Overgaauw M, Veltkamp M, Wijsenbeek MS; Collaborating investigators. Kahlmann V, et al. BMC Pulm Med. 2020 Oct 19;20(1):271. doi: 10.1186/s12890-020-01290-9. BMC Pulm Med. 2020. PMID: 33076885 Free PMC article.

7

Idiopathic pulmonary fibrosis: Current knowledge, future perspectives and its importance in radiation oncology.

Türkkan G, Willems Y, Hendriks LEL, Mostard R, Conemans L, Gietema HA, Mitea C, Peeters S, De Ruysscher D. Türkkan G, et al. Radiother Oncol. 2021 Feb;155:269-277. doi: 10.1016/j.radonc.2020.11.020. Epub 2020 Nov 24. Radiother Oncol. 2021. PMID: 33245945 Review.

8

The use of online visual analogue scales in idiopathic pulmonary fibrosis.

Moor CC, Mostard RLM, Grutters JC, Bresser P, Wijsenbeek MS. Moor CC, et al. Among authors: mostard rlm. Eur Respir J. 2022 Jan 13;59(1):2101531. doi: 10.1183/13993003.01531-2021. Print 2022 Jan. Eur Respir J. 2022. PMID: 34326190 Free PMC article.

9

Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis.

Bloem AEM, Mostard RLM, Stoot N, Vercoulen JH, Peters JB, Spruit MA. Bloem AEM, et al. Among authors: mostard rlm. J Thorac Dis. 2021 Aug;13(8):4872-4884. doi: 10.21037/jtd-21-462. J Thorac Dis. 2021. PMID: 34527326 Free PMC article.

10

Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study.

Miedema JR, Moor CC, Veltkamp M, Baart S, Lie NSL, Grutters JC, Wijsenbeek MS, Mostard RLM. Miedema JR, et al. Among authors: mostard rlm. Respir Res. 2022 May 28;23(1):139. doi: 10.1186/s12931-022-02061-2. Respir Res. 2022. PMID: 35643466 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page